Rise Advisors, LLC Equillium, Inc. Transaction History
Rise Advisors, LLC
- $249 Million
- Q3 2025
A detailed history of Rise Advisors, LLC transactions in Equillium, Inc. stock. As of the latest transaction made, Rise Advisors, LLC holds 263 shares of EQ stock, worth $397. This represents 0.0% of its overall portfolio holdings.
Number of Shares
263Holding current value
$397% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding EQ
# of Institutions
31Shares Held
11.5MCall Options Held
0Put Options Held
0-
Decheng Capital LLC Menlo Park, CA4.45MShares$6.72 Million0.35% of portfolio
-
Decheng Capital Management Iii (Cayman), LLC4.45MShares$6.72 Million1.82% of portfolio
-
Vanguard Group Inc Valley Forge, PA824KShares$1.24 Million0.0% of portfolio
-
Cota Capital Management, LLC San Francisco, CA562KShares$849,039100.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny274KShares$413,8910.0% of portfolio
About Equillium, Inc.
- Ticker EQ
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,352,100
- Market Cap $51.9M
- Description
- Equillium, Inc., a clinical-stage biotechnology company, develops and sells products to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need. The company's lead product candidate is itolizumab (EQ001), a clinical-stage monoclonal antibody that targets the novel immune checkpoint receptor CD6, which i...